Chongqing Pharscin Pharmaceutical Co., Ltd.

Chongqing Pharscin Pharmaceutical Co., Ltd. faced notable volatility on July 17, 2026, with its stock declining significantly. Despite a positive one-month performance, the company has struggled year-to-date and over the past year. Financial metrics reveal challenges, including low return on equity and negative net profit growth.

Chongqing Pharscin Pharmaceutical Co., Ltd. saw a notable increase in its stock today, contrasting with the broader market's performance. While the company has shown recent gains, it faces longer-term challenges, including declines in net sales and operating profit over the past five years, amidst a complex financial landscape.

Chongqing Pharscin Pharmaceutical Co., Ltd. has seen a notable increase in its stock today, contrasting with a decline in the broader market. While the company has shown strong weekly and modest monthly gains, it faces longer-term challenges with significant declines over the past year and year-to-date.